What Researchers Did
This clinical guideline reviewed existing evidence and cost analysis to assess the use of hyperbaric oxygen therapy (HBOt) for open fractures and crush injuries.
What They Found
The review concluded that medical institutions are justified in incorporating HBOt as a standard of care for open fractures and crush injuries, based on clinical evidence and cost analysis. Furthermore, crush injuries are listed as an approved indication for HBOt by both Medicare and the Undersea and Hyperbaric Medical Society guidelines.
What This Means for Canadian Patients
Canadian patients with open fractures or crush injuries may benefit from hyperbaric oxygen therapy (HBOt) as an adjunctive treatment. This therapy could potentially improve outcomes and become a more recognized part of their care.
Canadian Relevance
This study has no direct Canadian connection as it does not involve Canadian researchers, institutions, or patient populations.
Study Limitations
The guideline's recommendations are based on existing clinical evidence and cost analysis, which may vary in quality or completeness, and it does not present new primary research data.